Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuroscience Letters

• Publication date

  1994-09-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0304-3940(94)90948-2PMID 7845605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MK-801-induced stereotypy and its antagonism by neuroleptic drugs

  2005cited by this paper
• Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in rats

  2005cited by this paper
• D1/D2 dopamine and N-methyl-d-aspartate (NMDA) receptor participation in experimental catalepsy in rats

  2005cited by this paper
• The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

  2005cited by this paper
• Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acidA receptors

  1994cited by this paper
• Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.

  1993cited by this paper
• Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)5 an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

  1993cited by this paper
• Regionally Distinct N‐Methyl‐D‐Aspartate Receptors Distinguished by Quantitative Autoradiography of [3H]MK‐801 Binding in Rat Brain

  1993cited by this paper
• Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes

  1992cited by this paper
• Molecular diversity of the NMDA receptor channel

  1992cited by this paper
• Felbamate reduces hypoxic-ischemic brain damage in vivo.

  1992cited by this paper
• Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study.

  1992cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• Rodent Models of Parkinson’s Disease

  1992cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Anticataleptic potencies of glutamate-antagonists

  1991cited by this paper
• Felbamate for partial seizures

  1991cited by this paper
• Neuroleptic-induced catalepsy as a model of Parkinson's disease I. Effect of dopaminergic agents

  1990cited by this paper
• The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.

  1990cited by this paper
• The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones.

  1990cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Modulation of glutamate receptors: molecular mechanisms and functional implications.

  1989cited by this paper
• Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.

  1989cited by this paper
• The catalepsy test: its ups and downs.

  1988cited by this paper
• Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.

  1987cited by this paper
• Comparative Anticonvulsant Activity and Neurotoxicity of Felbamate and Four Prototype Antiepileptic Drugs in Mice and Rats

  1986cited by this paper
• Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens

  1986cited by this paper
• Pharmacokinetics of W‐554 (ADD 03055) in Epileptic Patients

  1985cited by this paper
• Behavioural functions of GABA in basal ganglia and limbic system

  1979cited by this paper
• Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  year unknowncited by this paper

• Significance of NMDA receptor-targeting compounds in neuropsychological disorders: An In-depth Review.

  2025cites this paper
• Drug repurposing for Parkinson’s disease by biological pathway based edge-weighted network proximity analysis

  2024cites this paper
• Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies

  2021influential citation
• The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs

  2009cites this paper
• Restoration and putative protection in parkinsonism

  2009cites this paper
• Ligands of the NMDA receptor-associated glycine recognition site and motor behavior

  2005cites this paper
• Restorative effects of glutamate antagonists in experimental parkinsonism

  2002cites this paper
• Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub-/suprathreshold doses of L-Dopa upon motor behaviour of MPTP-treated mice

  1999cites this paper
• Riluzole, a glutamate release inhibitor, and motor behavior

  1998cites this paper
• Behavioural pharmacology of glutamate receptors in the basal ganglia.

  1997cites this paper
• ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats.

  1997cites this paper
• 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.

  1996cites this paper
• Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens

  1996influential citation
• Balance of transmitter activities in the basal ganglia loops.

  1995cites this paper
• Electrophysiological actions of felbamate on rat striatal neurones

  1995cites this paper
• Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy.

  1995cites this paper